Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Neuronetics, Inc. Director's Dealing 2024

Dec 19, 2024

33660_dirs_2024-12-19_c7a68af5-6aa5-4fdb-9464-f60e11eb6d1a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Neuronetics, Inc. (STIM)
CIK: 0001227636
Period of Report: 2024-12-10

Reporting Person: Madryn Asset Management, LP (N/A)
Reporting Person: Madryn Health Partners II, LP (N/A)
Reporting Person: MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP (N/A)
Reporting Person: MADRYN HEALTH ADVISORS II, LP (N/A)
Reporting Person: MADRYN HEALTH ADVISORS GP II, LLC (N/A)
Reporting Person: Madryn Select Opportunities, LP (N/A)
Reporting Person: MADRYN SELECT ADVISORS, LP (N/A)
Reporting Person: MADRYN SELECT ADVISORS GP, LLC (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 24237061 Indirect

Footnotes

F1: In connection with the acquisition by Neuronetics, Inc. (the "Company") of all of the issued and outstanding common shares of Greenbrook TMS Inc. ("Greenbrook") on December 10, 2024 by way of a court-approved plan of arrangement under the Business Corporations Act (Ontario), each share of Greenbrook common stock held by the Reporting Persons was exchanged for 0.01021 shares of common stock of the Company.

F2: Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities," and, together with Health Partners and Cayman Master, the "Funds") directly hold 1,335,157, 20,259,096 and 2,642,808 shares of the Company's common stock ("Common Shares"), respectively. Madryn Asset Management, LP ("Madryn"), as investment advisor for each of the Funds; Madryn Health Advisors II, LP, as general partner of Health Partners and Cayman Master; Madryn Health Advisors GP II, LLC, as general partner of Madryn Health Advisors II, LP; Madryn Select Advisors, LP as general partner of Select Opportunities; and Madryn Select Advisors GP, LLC, as general partner of Madryn Select Advisors, LP, may be deemed to be beneficial owners of the shares held directly by the Funds.

F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.